Real life effect of an epoietin alpha biosimilar Retacrit® on response to chemotherapy-induced anemia and fatigue at 16 weeks in elderly patients (ELDER)

03/04/2018
03/04/2018
EU PAS number:
EUPAS23428
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

C3-Protocole_2015 09 07_EN

English (4.59 MB - PDF) View document
Study results
Study report
Other information